Target intelligence / Profile preview

G protein-activated inward rectifier potassium channel (GIRK)

Target
GIRK
Molecular classification
Ion channel, Inwardly rectifying potassium channel
01

Overview

G protein-activated inward rectifier potassium (GIRK) channels, also known as Kir3 channels, are a family of inwardly rectifying potassium channels that serve as critical effectors for various G protein-coupled receptors (GPCRs). These channels are directly activated by the Gβγ subunits of Gi/o proteins, allowing potassium ions to flow out of the cell and causing membrane hyperpolarization, which inhibits cellular activity [1][2]. In the cardiovascular system, GIRK1/GIRK4 heteromers (IKACh) are activated by acetylcholine to slow the heart rate, and their overactivity is linked to atrial fibrillation [3]. In the brain, GIRK channels (comprising GIRK1, GIRK2, and GIRK3) mediate the inhibitory effects of neurotransmitters like GABA, dopamine, and opioids, playing roles in pain modulation, reward pathways, and seizure prevention [1][4]. Mutations in the KCNJ5 gene (GIRK4) are a well-documented cause of primary aldosteronism and secondary hypertension due to loss of channel selectivity and subsequent sodium influx in the adrenal cortex [5]. Therapeutic strategies currently focus on developing selective GIRK inhibitors for treating cardiac arrhythmias and primary aldosteronism, as well as modulators for neurological and psychiatric disorders [2][4]. Sources: [1] Lüscher, C., & Slesinger, P. A. (2010). "Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease." Nature Reviews Neuroscience. [2] Hibino, H., et al. (2010). "Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles." Physiological Reviews. [3] Ehrlich, J. R. (2008). "Inward rectifier potassium channels as a target for antiarrhythmic drug development." Current Opinion in Drug Discovery & Development. [4] Rifkin, R. A., et al. (2017). "G protein-gated inwardly rectifying potassium (GIRK) channels: A potential target for the treatment of chronic pain." Channels. [5] Choi, M., et al. (2011). "K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension." Science.

Other names
Kir3 channelG protein-gated inwardly rectifying potassium channelKCNJ channelG protein-coupled inwardly rectifying potassium channel
02

Mechanism of action

Direct activation by the G-beta-gamma (Gβγ) subunits of heterotrimeric G proteins following the stimulation of G protein-coupled receptors (GPCRs), leading to potassium efflux and cellular hyperpolarization; pharmacological agents may either block these channels to increase excitability (e.g., in cardiac arrhythmia) or modulate them to restore normal signaling.

03

Biological functions

Signal transductionMembrane hyperpolarizationPotassium ion transportHeart rate regulationNeuronal inhibitionRegulation of resting membrane potential
04

Disease associations

Atrial fibrillationPrimary aldosteronismEpilepsyDrug addictionChronic painParkinson's diseaseHypertension
05

Safety considerations

Pro-arrhythmic riskBradycardiaImpact on cardiac conduction (AV block)Central nervous system side effectsElectrolyte disturbances
06

Interacting drugs

Adenosine

7 more in the full profile.

07

Biomarkers

Plasma aldosterone-to-renin ratio (PAC/PRC)P-wave duration on electrocardiogramHeart rate variability

Beyond the preview

Go deeper on G protein-activated inward rectifier potassium channel (GIRK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-activated inward rectifier potassium channel (GIRK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call